The Government Accounting Office, of all entities, has weighed in health quality measures. (GAO Report) The GAO was actually asked by Congress to look at whether there were issues relating to the disparate measures developed and implemented by HHS and private payers and what burden this might impose on providers. GAO’s review found that there are not a lot of quality measures were used in common by CMS, other public payers and commercial health plans. This lack of commonality increases the administrative burden on providers, de-focuses and diffuses their quality improvement efforts and gives confusing information to consumers. Three primary factors were identified for this lack of overlap. One is that payers and other stakeholders make independent, uncoordinated decisions about which measures to use. Another is variation in data collection and reporting systems. And the final one is the widespread perception that many of the developed, and adopted, measures aren’t really particularly meaningful to patients, providers or payers. The report acknowledges that CMS has made efforts to begin working with private payers to adopt a common set of core quality measures and has worked toward identifying ways electronic data collection and reporting could lessen the administrative burden on providers. But the GAO also said that CMS and HHS haven’t prioritized this work and don’t have a comprehensive plan or timeline to complete it. This is a critical point, particularly as more and more payers use quality results to impact provider reimbursements. Some providers have just given up and accepted penalties rather than deal with the plethora of measures. This is obviously not a good outcome. A joint working group across providers and payers should come up with a very limited set of real outcomes measures, and perhaps process measures that have an indisputable link to outcomes, and those are the only measures that providers should be required to use.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
October 4, 2023
Electric Cars for Everyone, so Rich People Can Get Richer
Everything about electric cars is expensive, including insurance, but rich people get richer from them.
Commentary
October 3, 2023
Minnesota’s Modeling Nightmare
Minnesota finally wants to figure out how epidemic modeling was so bad, but the Strib…
Commentary
October 3, 2023
Reality Intrudes Again on the Renewable Energy Delusion
Solar and wind power are the most expensive forms of electricity and the cost of…